Skip to main content
Caplight Logo









Qinotto, Inc.

Qinotto, Inc.

Private
San Carlos, CaliforniaHealthcare & Life Scienceshttps://www.qinotto.com/

Last Round

Grant

Dec 15, 2021

Total Funding Raised

$1M

Company Overview

Qinotto, Inc. operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Grant round in December 2021.

Qinotto, Inc. is a biotechnology company that develops novel blood-brain barrier transport vehicles to deliver large molecule therapeutics to the brain.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Qinotto, Inc. Comparables

Compare Qinotto, Inc. with similar companies based on industry and business-model similarity.

Qinotto, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AbbVie
81%
Denali Therapeutics
79%
Gate2Brain
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Qinotto, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 15, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Qinotto, Inc. Investors

Notable investors and investment history

Qinotto, Inc. investors
InvestorRounds
Remiges VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 15, 2021

    $1M grant received from Alzheimer's Association.

Book a demo to see all signals

For institutional investors. Book with your work email.

Qinotto, Inc. Filings

Explore SEC and related filing metadata, where available.

Qinotto, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Qinotto, Inc.'s valuation, stock price, and market status.

Is Qinotto, Inc. a public or private company?

Qinotto, Inc. is a private company.

What is the current stock price of Qinotto, Inc.?

Qinotto, Inc. is a private company, so its shares have no public market price. Caplight tracks Qinotto, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Qinotto, Inc. worth (valuation)?

Valuation information for Qinotto, Inc. is not publicly available.

Can I buy Qinotto, Inc. stock?

Qinotto, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Qinotto, Inc.'s last funding round?

Qinotto, Inc.'s most recent funding round was Grant on December 15, 2021.

Who are the main investors in Qinotto, Inc.?

Key investors in Qinotto, Inc. include Remiges Ventures.

Will Qinotto, Inc. IPO soon?

No public IPO plans have been announced for Qinotto, Inc..

How can I track Qinotto, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Qinotto, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersSan Carlos, California
Year Founded2019
Last FundingDec 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?